Cognex Corporation CGNX
58.66
0.96
1.66%
as of 25 Sep
- Market cap
- $9.8B
- P/E
- 55.9×
Follow CGNX
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
68.97 | 56.97 | 52.14 | 68.64 |
+8 more quarters Free account |
P/S ratio |
11.13 | 7.79 | 6.08 | 7.82 | |
P/FCF ratio |
45.81 | 34.37 | 25.95 | 37.39 | |
P/Operating CF |
175.25 | 180.90 | 80.72 | 86.91 | |
P/B ratio |
7.44 | 5.52 | 4.05 | 5.10 | |
Price to Tangible BV |
10.24 | 7.93 | 5.90 | 7.52 | |
EV/Sales |
10.76 | 7.51 | 5.74 | 7.52 | |
EV/EBITDA |
43.93 | 34.83 | 29.64 | 38.66 | |
EV/Operating CF |
42.35 | 31.43 | 23.26 | 32.89 | |
EV/FCF |
44.29 | 33.12 | 24.50 | 35.92 | |
Quick Ratio |
2.87 | 2.47 | 2.64 | 2.69 | |
Current Ratio |
3.93 | 3.64 | 3.80 | 3.96 | |
Net Debt/EBITDA |
(4.38) | (4.42) | (7.96) | (4.63) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.52 | 0.53 | 0.50 | 0.48 | |
Operating CF/Net income |
0.95 | 0.87 | 2.29 | 4.95 | |
Capex/Depreciation |
(0.22) | (0.38) | 0.58 | (0.20) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
11.12% | 13.79% | 14.29% | 12.67% | |
Selling, General and Administrative Expense of Revenue |
30.17% | 35.03% | 37.48% | 34.11% | |
Intangible Assets out of Total Assets |
0.20 | 0.22 | 0.23 | 0.24 | |
Share Based Compensation of Revenue |
3.85% | 4.45% | 5.50% | 4.48% | |
Graham Net Nets |
0.02 | 0.02 | 0.03 | 0.02 | |
Graham Number |
15.17 | 13.11 | 11.74 | 11.48 | |
Earnings Yield |
1.45% | 1.76% | 1.92% | 1.46% | |
Free Cash Flow Yield |
2.18% | 2.91% | 3.85% | 2.67% | |
Revenue per Share |
1.74 | 1.61 | 1.50 | 1.65 | |
Operating CF per Share |
0.41 | 0.27 | 0.45 | 0.52 | |
Capex per Share |
(0.01) | (0.02) | 0.02 | (0.01) | |
Free Cash Flow per Share |
0.40 | 0.25 | 0.47 | 0.51 | |
Cash per Share |
2.42 | 1.78 | 2.01 | 1.79 | |
Shareholders Equity per Share |
9.74 | 8.88 | 8.88 | 8.88 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.74 | 8.88 | 8.88 | 8.88 | |
Free Cash Flow |
67.62 | 42.34 | 79.01 | 86.03 | |
Working Capital |
633.85 | 500.86 | 513.70 | 501.65 | |
Capital Expenditures |
(1.53) | (2.76) | 4.11 | (1.45) | |
Net Current Asset Value |
300.79 | 163.70 | 172.59 | 157.81 | |
EV/EBIT |
49.13 | 40.04 | 35.12 | 46.18 | |
Capex to Sales |
0.01 | 0.01 | (0.02) | 0.01 | |
Net Profit Margin |
24.98% | 19.26% | 12.94% | 6.38% | |
Price to Operating Income |
50.83 | 41.55 | 37.19 | 48.08 | |
| Other line items | |||||
Average Receivables |
200.09 | 165.95 | 145.04 | 156.29 | |
Average Payables |
53.67 | 51.43 | 44.12 | 37.73 | |
Average Inventory |
143.71 | 143.83 | 147.71 | 149.48 | |
Average Assets |
2,091.10 | 1,969.06 | 2,004.70 | 2,033.00 | |
Average Common Equity |
1,567.81 | 1,462.30 | 1,504.70 | 1,528.33 |
Columns are period end dates